MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216

Author(s):
Reijers, J.A.A.; Kallend, D.G.; Malone, K.E.; Jukema, J.W. (0000-0002-3246-8359); Wijngaard, P.L.J.; Burggraaf, J.; Moerland, M.
Published
2017
Publication type
Article / Letter to editor
ImmunostimulationMDCO-216ETC-216Ex vivo stimulationApolipoprotein A-I Milano
Date issued
2017-08-31
Language
English
Is part of
Cardiovascular Drugs and Therapy (2017), Vol. 31, no. 4, p. 381-389
hdl
1887/95096
doi
10.1007/s10557-017-6746-x